✦ LIBER ✦

Clearing of globotriaosylceramide from endothelial vessels of ocular conjunctiva in patients with Fabry disease treated with agalsidase alfa

✍ Scribed by P. Rozenfeld; R. Ebner; O. Croxatto; C. Fossati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of agalsidase alfa in m

✍ KS Loveday; C Brucato; T Colasurdo; R Gamble; J Lieb; M Sellos-Moura; T Schuetz; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Safety of agalsidase alfa in patients wi

✍ U Ramaswami; R Parini; C Kampmann; M Beck 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Evaluation of glycosphingolipid clearanc

✍ Barranger, John A.; Gambello, Michael J.; Goker-Alpan, Ozlem; Maegawa, Gustavo H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Enzyme replacement therapy with agalsida

✍ A Mehta; M Beck; P Elliott; R Giugliani; A Linhart; G Sunder-Plassmann; R Schiff 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 253 KB

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Evaluation of Plasma Globotriaosylsphing

✍ Charles Lourenco; Janice Coelho; Miguel Moyses Neto; Osvaldo Merege Vieira Neto; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB